Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Comparison of pyogenic postoperative and native vertebral osteomyelitis.

Kim UJ, Bae JY, Kim SE, Kim CJ, Kang SJ, Jang HC, Jung SI, Song KH, Kim ES, Kim HB, Park WB, Kim NJ, Park KH.

Spine J. 2018 Nov 27. pii: S1529-9430(18)31251-8. doi: 10.1016/j.spinee.2018.11.012. [Epub ahead of print]

PMID:
30500465
2.

Outcome of culture-negative pyogenic vertebral osteomyelitis: comparison with microbiologically confirmed pyogenic vertebral osteomyelitis.

Kim J, Kim YS, Peck KR, Kim ES, Cho SY, Ha YE, Kang CI, Chung DR, Song JH.

Semin Arthritis Rheum. 2014 Oct;44(2):246-52. doi: 10.1016/j.semarthrit.2014.04.008. Epub 2014 Apr 26.

PMID:
24951277
3.

Native vertebral osteomyelitis in aged patients: distinctive features. An observational cohort study.

Aguilar-Company J, Pigrau C, Fernández-Hidalgo N, Rodríguez-Pardo D, Falcó V, Lung M, Pellisé F, Almirante B.

Infection. 2018 Oct;46(5):679-686. doi: 10.1007/s15010-018-1177-6. Epub 2018 Jul 12.

PMID:
30003490
4.

Outcomes of multilevel vertebrectomy for spondylodiscitis.

Ackshota N, Nash A, Bussey I, Shasti M, Brown L, Vishwanath V, Malik Z, Banagan KE, Koh EY, Ludwig SC, Gelb DE.

Spine J. 2019 Feb;19(2):285-292. doi: 10.1016/j.spinee.2018.06.361. Epub 2018 Aug 3.

PMID:
30081094
5.

Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case-control study.

Lemaignen A, Ghout I, Dinh A, Gras G, Fantin B, Zarrouk V, Carlier R, Loret JE, Denes E, Greder A, Lescure FX, Boutoille D, Tattevin P, Issartel B, Cottier JP, Bernard L; DTS (Duration of Treatment for Spondylodiscitis) study group.

Medicine (Baltimore). 2017 May;96(21):e6387. doi: 10.1097/MD.0000000000006387.

6.

Bone morphogenetic protein-2 (BMP-2) in the treatment of pyogenic vertebral osteomyelitis.

Allen RT, Lee YP, Stimson E, Garfin SR.

Spine (Phila Pa 1976). 2007 Dec 15;32(26):2996-3006.

PMID:
18091493
7.

Long-term outcome of pyogenic vertebral osteomyelitis: a cohort study of 260 patients.

Gupta A, Kowalski TJ, Osmon DR, Enzler M, Steckelberg JM, Huddleston PM, Nassr A, Mandrekar JM, Berbari EF.

Open Forum Infect Dis. 2014 Dec 5;1(3):ofu107. doi: 10.1093/ofid/ofu107. eCollection 2014 Dec.

8.

Pyogenic vertebral osteomyelitis: identification of microorganism and laboratory markers used to predict clinical outcome.

Yoon SH, Chung SK, Kim KJ, Kim HJ, Jin YJ, Kim HB.

Eur Spine J. 2010 Apr;19(4):575-82. doi: 10.1007/s00586-009-1216-1. Epub 2009 Nov 24.

9.

Single-stage treatment of pyogenic spinal infection with titanium mesh cages.

Kuklo TR, Potter BK, Bell RS, Moquin RR, Rosner MK.

J Spinal Disord Tech. 2006 Jul;19(5):376-82.

PMID:
16826013
10.

Diagnosis and management of primary pyogenic spinal infections in intravenous recreational drug users.

Ziu M, Dengler B, Cordell D, Bartanusz V.

Neurosurg Focus. 2014 Aug;37(2):E3. doi: 10.3171/2014.6.FOCUS14148.

PMID:
25081963
11.

Clinical effect of early bisphosphonate treatment for pyogenic vertebral osteomyelitis with osteoporosis: An analysis by the Cox proportional hazard model.

Kim J, Jang SB, Kim SW, Oh JK, Kim TH.

Spine J. 2019 Mar;19(3):418-429. doi: 10.1016/j.spinee.2018.08.014. Epub 2018 Aug 30.

PMID:
30172897
12.

Changing trends in the epidemiology of pyogenic vertebral osteomyelitis: the impact of cases with no microbiologic diagnosis.

Lora-Tamayo J, Euba G, Narváez JA, Murillo O, Verdaguer R, Sobrino B, Narváez J, Nolla JM, Ariza J.

Semin Arthritis Rheum. 2011 Oct;41(2):247-55. doi: 10.1016/j.semarthrit.2011.04.002. Epub 2011 Jun 12.

PMID:
21665246
13.

Pyogenic vertebral osteomyelitis of the elderly: Characteristics and outcomes.

Courjon J, Lemaignen A, Ghout I, Therby A, Belmatoug N, Dinh A, Gras G, Bernard L; DTS (Duration of Treatment for Spondylodiscitis) study group.

PLoS One. 2017 Dec 5;12(12):e0188470. doi: 10.1371/journal.pone.0188470. eCollection 2017.

14.

Medical and surgical treatment of pyogenic spondylodiscitis.

Pola E, Logroscino CA, Gentiempo M, Colangelo D, Mazzotta V, Di Meco E, Fantoni M.

Eur Rev Med Pharmacol Sci. 2012 Apr;16 Suppl 2:35-49. Review.

PMID:
22655482
15.

Epidemiology, Microbiological Diagnosis, and Clinical Outcomes in Pyogenic Vertebral Osteomyelitis: A 10-year Retrospective Cohort Study.

Chong BSW, Brereton CJ, Gordon A, Davis JS.

Open Forum Infect Dis. 2018 Mar 10;5(3):ofy037. doi: 10.1093/ofid/ofy037. eCollection 2018 Mar.

16.

Successful use of tigecycline for treatment of culture-negative pyogenic vertebral osteomyelitis.

Seyman D, Berk H, Sepın-Ozen N, Kızılates F, Turk CC, Buyuktuna SA, Inan D.

Infect Dis (Lond). 2015;47(11):783-8. doi: 10.3109/23744235.2015.1062132. Epub 2015 Jun 24.

PMID:
26107887
17.

Pyogenic, tuberculous, and brucellar vertebral osteomyelitis: a descriptive and comparative study of 219 cases.

Colmenero JD, Jiménez-Mejías ME, Sánchez-Lora FJ, Reguera JM, Palomino-Nicás J, Martos F, García de las Heras J, Pachón J.

Ann Rheum Dis. 1997 Dec;56(12):709-15.

18.

Postoperative infection in spine surgery: does the month matter?

Durkin MJ, Dicks KV, Baker AW, Moehring RW, Chen LF, Sexton DJ, Lewis SS, Anderson DJ.

J Neurosurg Spine. 2015 Jul;23(1):128-34. doi: 10.3171/2014.10.SPINE14559. Epub 2015 Apr 10.

19.

Diagnostic performance of pyogenic vertebral osteomyelitis.

Moromizato T, Harano K, Oyakawa M, Tokuda Y.

Intern Med. 2007;46(1):11-6. Epub 2007 Jan 1.

20.

Supplemental Content

Support Center